Adelaide Fernandes
@fernandes_lab
Followers
90
Following
94
Media
7
Statuses
42
Our lab focuses on the role of inflammation in the emergence or progression of neurodevelopment and neurodegenerative disorders.
Joined May 2021
Another great presentation by @AlexandreNeto at #MindBrain2024 sharing our most recent results on the impact of Obesity in Multiple Sclerosis. @facfarmaciaUL @iMedULisboa @GlialRede
0
0
4
Great presentation by @CatarinaBarros at #MindBrain2024 sharing our most recent results on the role of Microglia in Multiple Sclerosis cognitive impairment. @facfarmaciaUL @iMedULisboa @GlialRede
0
0
4
Gain In-Depth Knowledge in "Advances in Neuropathology and Innovative Therapeutic Interventions". Join us next September! Enroll Now and Elevate Your Scientific Journey. 🧠💊. @facfarmaciaUL @iMedULisboa @GlialRede #Education #Research
0
1
1
Proud of @CatarinaBarros and @AlexandreNeto for presenting our results in the Annual meeting of @iMedULisboa at @facfarmaciaUL ! Great job!
0
0
6
Great discussion at @iMedULisboa Annual meeting organized by our @ipSC PhD students committee at @facfarmaciaUL
0
1
5
Great joint venture between @GlialRede and @redglial and a pleasure to co-chair with @FdeCastroS ! Our excelent speakers #Patrick_Kury, #Ana_Mendanha_Falcao, #Lucas_Schirmer and #Alanna_Hoffmann (@MironLab). #FENSForum2024 #ibro.
Proud of the @GlialRede+@redglial (@fernandes_lab+myself) symposium on #MultipleSclerosis from different #glial perspectives,cherry of a superb #FENS2024: #Patrick_Küry,#Mendanha_Falcao,@schirmerlab & Alana_Hoffmann (@MironLab) showed us many great actors to know+treat #MS.
0
4
14
RT @MatuteC_: Historical gathering of #EuropeanGlialNetworks #FENS2024! Fostering collaborations & activities to progress towards creating….
0
18
0
If you want to know more about microglia synapse prunning in Multiple Sclerosis join us at poster #339 at #FENSForum2024 . @GlialRede @iMedULisboa @facfarmaciaUL
0
2
12
Great networking with Glial Networks @GlialRede at #FENS2024.
Glial Network 'net'working at #FENS2024! @GlialRede @UKGlia @ATgliaNet @GlialClub @AstrocyteCafe @italianglianet @GLIA_Journal #EuropeanGlialNetworks
0
0
5
RT @SENC_: 📢La @redglial y la @GlialRede organizan en #FENS2024 el simposio 'Diverse #glial contribution to demyelination and Multiple Scle….
0
17
0
Parabéns Catarina! Excelente visão sobre o trabalho em curso!. Para além do visível: desmistificar os sintomas da esclerose múltipla
publico.pt
Desconhecendo-se os mecanismos na origem e progressão da esclerose múltipla, esta investigação tenta desvendar a complexidade de um sintoma incapacitante e muitas vezes invisível: o défice cognitivo.
0
1
5
Neuropharmaceutics focuses on the identification of therapeutic targets in nervous system diseases, and then translating those discoveries into drug and therapy development. Check our programme with great speakers and join us in September! registrations at
PhD Avdanced Course “Advances in Neuropharmaceutics” Registrations up to 7th of September. Contact: doutoramentos@ff.ulisboa.pt. Course Coordinator: Adelaide Fernandes
0
1
5
RT @GlialRede: The first seminar of the GLIA sessions will be by Veronique Miron and it is entitled “The disappearing act: how microglia su….
0
8
0
RT @iMedULisboa: There’s an open call for applications for a Research Grant for the project "Development of a therapy for the use of autolo….
0
1
0
RT @facfarmaciaUL: #Lastcall | Inscrições terminam a 06/12/2021. O programa incide em cinco tópicos: "Neuro-immunology, Neuro-oncology, #Co….
0
1
0
RT @GlialRede: Great start with @headimmune addressing the immunological party taking place in the brain
0
2
0
Join us at
Vem aí a 2.ª edição… #Formação avançada para doutorandos. Programa com ênfase na #descoberta de potenciais alvos de doenças do #Sistema Nervoso Central. Inscrições abertas até 06/12/2021.
0
0
1
If you have curiosity to discover more on Neuropharmaceutics. Don't miss our next PhD course:
0
0
0
RT @facfarmaciaUL: Vem aí a 2.ª edição… #Formação avançada para doutorandos. Programa com ênfase na #descoberta de potenciais alvos de doen….
0
1
0